RE:RE:MDP is undervalued and that puzzles meI doubled my holdings yesterday on the pull back. I'm convinced like you that this will be duble in less than a year and $40 to $60 in a few years. This is a long time hold for me. Management is doing a great job and yes once on the Nas they should think about PR but that cost money and they need those fund to acquire rights to more product. Treosulfan will bump earning but I think it could go to $200M or $250M added revenue.